All Industries

Top Biotech Companies

3,138 Biotech companies, sorted by total funding raised.

Simtra BioPharma Solutions

Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...

Bloomington, United States1001–5000Biotech, Contract Manufacturing
Private Equity·$4.3B·Oct 2023
Isomorphic Labs

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

London, United Kingdom201–500Artificial Intelligence, Biotech
Venture Unknown·$3.2B·May 2026
Impossible Foods

Food technology company creating plant-based meat and dairy products that replicate the taste and...

Redwood City, United States501–1000Agtech, Biotech
Series G Plus·$2.4B·Nov 2021
AsymchemIPO

Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.

Tianjin, China5001–10000Healthcare, Biotech
Private Equity·$2.3B·Feb 2020
Hugel

South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...

Chuncheon, South Korea201–500Aesthetics, Biotech
Private Equity·$2.3B·Aug 2021
N
Novotech

Global full-service clinical research organization (CRO) and scientific advisory partner for biot...

Sydney, Australia1001–5000Biotech, Healthcare
Growth Equity·$1.9B·Mar 2025
Celerion (H.I.G. Capital)

Global clinical research organization specializing in early-stage clinical trials and bioanalytic...

Lincoln, United States501–1000Biotech, Healthcare
Private Equity·$1.8B·Apr 2026
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Life Sciences
Series D·$1.4B·Jun 2020
Roivant

Healthcare company applying technology to drug development by building nimble biotech subsidiarie...

New York, United States501–1000Biotech, Healthcare
Growth Equity·$1.3B·Nov 2018
Denali TherapeuticsIPO

Denali Therapeutics is a biotechnology company focused on discovering and developing treatments f...

South San Francisco, United States201–500Biotech, healthtech
Venture Unknown·$1.3B·Dec 2025
Neuralink

Neuralink is building a brain-computer interface for medical needs and greater human potential.

Fremont, United States201–500Biotech, Healthcare
Series E·$1.2B·Jun 2025
Treeline Biosciences

Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...

Watertown, United States51–200Biotech, Drug Discovery
Extension Round·$1.2B·Sep 2025
Curie.Bio

Biotech venture firm and therapeutics accelerator that invests at seed stage and acts as a drug d...

Boston, United States1–10Biotech, Drug Discovery
Seed·$1.2B·Jan 2025
Solugen

Decarbonizing the chemicals industry.

Houston, United States51–200Biotech, Climate Tech
Venture Unknown·$1.2B·Mar 2026
Oxford Nanopore Technologies

UK biotech company making portable DNA/RNA nanopore sequencing devices for real-time analysis any...

London, United Kingdom1001–5000Nanopore Sequencing, Biotech
Funding undisclosed
Abogen Biosciences

China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.

Suzhou, China201–500Biotech, mRNA Therapeutics
Extension Round·$1.1B·Nov 2021
A
Abogen

Clinical-stage biotech company developing transformative medicines through mRNA and lipid nanopar...

ChinaBiotech
Series C·$1.1B·Nov 2021
Eikon TherapeuticsIPO

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...

Hayward, United States201–500Artificial Intelligence, Drug Discovery
Series D·$1.1B·Feb 2025
GeneDxIPO

Genetic testing company specializing in rare disease diagnostics through whole exome and genome s...

Stamford501–1000Biotech, Healthcare
Corporate Round·$1.0B·Jan 2022
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate Round·$1.0B·Apr 2020
Kry

European digital healthcare platform connecting patients with licensed doctors via video consulta...

Stockholm, Sweden1001–5000Healthcare, Biotech
Venture Unknown·$1.0B·Apr 2025
ArsenalBio

Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...

San Francisco, United States201–500Biotech, Life Sciences
Series C·$955.0M·Sep 2024
Lila Sciences

Scientific superintelligence platform building autonomous AI labs for life, chemical, and materia...

Cambridge, United States51–200Artificial Intelligence, Biotech
Extension Round·$950.0M·Oct 2025
ZymergenClosed

Zymergen was a biomanufacturing company using AI and machine learning to engineer microbes for pr...

Emeryville, United States501–1000Advanced Materials, Artificial Intelligence
Series D·$928.1M·Sep 2020
BridgeBioIPO

BridgeBio makes targeted treatments for genetic diseases.

San Francisco Bay Area, United States201–500Biotech, Life Sciences
Convertible·$909.2M·Mar 2020